RESUMEN
BACKGROUND: Although prolactinomas are treated effectively with dopamine agonists, some have proposed curative surgical resection for select cases of microprolactinomas to avoid life-long medical therapy. We performed a cost-effectiveness analysis comparing transsphenoidal surgery (either microsurgical or endoscopic) and medical therapy (either bromocriptine or cabergoline) with decision analysis modeling. METHODS: A 2-armed decision tree was created with TreeAge Pro Suite 2012 to compare upfront transsphenoidal surgery versus medical therapy. The economic perspective was that of the health care third-party payer. On the basis of a literature review, we assigned plausible distributions for costs and utilities to each potential outcome, taking into account medical and surgical costs and complications. Base-case analysis, sensitivity analysis, and Monte Carlo simulations were performed to determine the cost-effectiveness of each strategy at 5-year and 10-year time horizons. RESULTS: In the base-case scenario, microscopic transsphenoidal surgery was the most cost-effective option at 5 years from the time of diagnosis; however, by the 10-year time horizon, endoscopic transsphenoidal surgery became the most cost-effective option. At both time horizons, medical therapy (both bromocriptine and cabergoline) were found to be more costly and less effective than transsphenoidal surgery (i.e., the medical arm was dominated by the surgical arm in this model). Two-way sensitivity analysis demonstrated that endoscopic resection would be the most cost-effective strategy if the cure rate from endoscopic surgery was greater than 90% and the complication rate was less than 1%. Monte Carlo simulation was performed for endoscopic surgery versus microscopic surgery at both time horizons. This analysis produced an incremental cost-effectiveness ratio of $80,235 per quality-adjusted life years at 5 years and $40,737 per quality-adjusted life years at 10 years, implying that with increasing time intervals, endoscopic transsphenoidal surgery is the more cost-effective treatment strategy. CONCLUSIONS: On the basis of the results of our model, transsphenoidal surgical resection of microprolactinomas, either microsurgical or endoscopic, appears to be more cost-effective than life-long medical therapy in young patients with life expectancy greater than 10 years. We caution that surgical resection for microprolactinomas be performed only in select cases by experienced pituitary surgeons at high-volume centers with high biochemical cure rates and low complication rates.
Asunto(s)
Bromocriptina/uso terapéutico , Árboles de Decisión , Ergolinas/uso terapéutico , Costos de la Atención en Salud , Antagonistas de Hormonas/uso terapéutico , Hiperprolactinemia/tratamiento farmacológico , Microcirugia/economía , Neuroendoscopía/economía , Neoplasias Hipofisarias/economía , Neoplasias Hipofisarias/terapia , Prolactinoma/economía , Prolactinoma/terapia , Adulto , Anciano , Bromocriptina/economía , Cabergolina , Análisis Costo-Beneficio , Técnicas de Apoyo para la Decisión , Ergolinas/economía , Femenino , Antagonistas de Hormonas/economía , Humanos , Hiperprolactinemia/etiología , Esperanza de Vida , Masculino , Medicare , Microcirugia/métodos , Persona de Mediana Edad , Método de Montecarlo , Neuroendoscopía/métodos , Neoplasias Hipofisarias/complicaciones , Neoplasias Hipofisarias/tratamiento farmacológico , Neoplasias Hipofisarias/cirugía , Prolactinoma/complicaciones , Prolactinoma/tratamiento farmacológico , Prolactinoma/cirugía , Años de Vida Ajustados por Calidad de Vida , Seno Esfenoidal/cirugía , Factores de Tiempo , Resultado del Tratamiento , Estados UnidosRESUMEN
The provision of care and business of musculoskeletal medicine have evolved signifncalty over the last two decades. It has become ever more important that those who are leading muskuloskeletal medicine practices evolve with the changing healthcare landscape and find new ways to provide higher quliaty and more cost-effetive care. To meet these new challenges, many orthopedic physicians are choosing to hire athletic trainers as a part of their office staff. Athletic trainers provide value to a medical practice through their skills in triage, taking patient histories, performing musculoskeletal evaluations, providing instruction on exercise prescription, rehabilitation, and general patient education. If a practice can become more efficient by narroworring staff to a single ancillary provider that encompasses several skills at a high level, this is where patient throughput and patient satisfaction scores can be improved by the athletic trainer as a physician extender.
Asunto(s)
Técnicos Medios en Salud/economía , Eficiencia Organizacional/economía , Ortopedia , Administración de la Práctica Médica/economía , Rol Profesional , Humanos , Satisfacción del PacienteRESUMEN
PURPOSE: The aim of this study was to compare the readability of online patient education materials among academic otolaryngology departments in the mid-Atlantic region, with the purpose of determining whether these commonly used online resources were written at a level readily understood by the average American. METHODS: A readability analysis of online patient education materials was performed using several commonly used readability assessments including the Flesch Reading Ease Score, the Flesch-Kincaid Grade Level, Simple Measure of Gobbledygook, Gunning Frequency of Gobbledygook, the New Dale-Chall Test, the Coleman-Liau Index, the New Fog Count, the Raygor Readability Estimate, the FORCAST test, and the Fry Graph. RESULTS: Most patient education materials from these programs were written at or above an 11th grade reading level, considerably above National Institutes of Health guidelines for recommended difficulty. CONCLUSIONS: Patient educational materials from academic otolaryngology Web sites are written at too difficult a reading level for a significant portion of patients and can be simplified.